BOT - Botanix Pharmaceuticals Limited - Strawman: ASX share price, valuation, research and discussion

Top member reports

Company Report

Last edited 5 months ago

ranked

#102

Performance (19m)

38.5% pa

Followed by

Straws

Sort by:

Recent

Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.

Become a member

#Analyst Report

Added 5 months ago

Change from ‘Speculative Buy’ to ‘Buy’ and a change of target price from $0.33 to $0.47 now things have been de-risked via FDA approval.

Botanix Pharmaceuticals Limited